New MS Clinic to Provider Specialty Care in Utah County

August 4, 2025
Published
Author

More to read

October 21, 2026
Why Is Misdiagnosis So Common With Multiple Sclerosis?
Misdiagnosis of multiple sclerosis is more common than many realize. ANC neurologist Dr. Elijah Lackey explains how other conditions can mimic MS on MRI and why consulting a neurologist with specialized MS training is important for an accurate diagnosis.
Clinical Excellence
Real-world Evidence
Learn More
September 11, 2026
Scholar Rock Announces FDA Approval of ISEMBYLD™ (apitegromab-mstn), the First and Only Muscle-Targeted Treatment for Children and Adults with Spinal Muscular Atrophy (SMA)
The FDA approval of ISEMBYLD™ brings a new treatment option to the SMA community. At CTNC, Dr. Adam Horvit and our team care for six patients receiving apitegromab through an Expanded Access Program.
Clinical Excellence
Real-world Evidence
Learn More
September 25, 2025
Nira Medical at ECTRIMS 2025
At ECTRIMS 2025, Dr. John Foley joined experts from around the world to explore how AI-powered analysis of real-world clinical data can provide new insights into drug efficacy, safety, and outcomes in multiple sclerosis. He was joined at the meeting by many neurologists and APPs from across the Nira Medical network, who participated in research presentations, discussions, and the broader exchange of ideas in MS care.
Research
Learn More